However, as CD47 is also expressed on noncancerous cells, such as platelets and red blood cells, delivering this antibody locally via our gel, rather than systemically, is advantageous to avoid known on‐target‐off‐cancer toxicities.14, 66, 67. Here, CD47 is linked to cancer.